Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-15

FDA Approved: NOVOLIN R — Supplemental Application (Novo Nordisk)

View source ↗

Summary

The FDA approved Novo Nordisk's supplemental application for NOVOLIN R (human insulin).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NOVOLIN R (HUMAN INSULIN)

Snippet

SUPPL AP for NOVOLIN R (HUMAN INSULIN)